|Bedaquiline, the first new medicine to fight drug-resistant tuberculosis in more than 40 years, is now available in Viet Nam. — Photo tuoitre.vn
HA NOI (VNS) — Bedaquiline, the first new medicine to fight drug-resistant tuberculosis in more than 40 years, is now available in Viet Nam, the United States Agency for International Development (USAID) said yesterday.
This new medication has been developed through a partnership between USAID and Janssen Therapeutics of Johnson & Johnson. This partnership has proved to be a significant step forward in the global fight against the growing threat of antibiotic-resistant bacteria.
Tuberculosis remains one of the most common communicable diseases in Viet Nam, with 130,000 new cases and 17,000 deaths being reported every year. Viet Nam is among the first countries in the world to receive the Bedaquiline donation to support its continuing battle against the disease. — VNS